Discontinuation report AVAPRO
| Report ID | 229306 |
| Drug Identification Number | 02237923 |
| Brand name | AVAPRO |
| Common or Proper name | Irbesartan |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | IRBESARTAN |
| Strength(s) | 75MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 90 count bottle |
| ATC code | C09CA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, PLAIN |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2024-11-30 |
| Actual discontinuation date | |
| Remaining supply date | 2024-11-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Company business decision |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-05-31 | French | Compare |
| v1 | 2024-05-31 | English | Compare |
Showing 1 to 2 of 2